Hongbo Yang

5PUBLICATIONS
13CO-AUTHORS
Cell physiologyGene and molecular therapyOncology and carcinogenesis not elsewhere classifiedPharmaceutical delivery technologiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
Real-world treatment patterns and clinical outcomes of patients with primary biliary cholangitis in the United States.

|Jul 11, 2024
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.

Celine Labeyrie, Madeline Merkel, Sakshi Sethi

|Jan 14, 2022
Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma.

Richard T Maziarz, Jie Zhang, Hongbo Yang

|Dec 18, 2021
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials.

Mark G Lebwohl, Ahmed M Soliman, Hongbo Yang

|Oct 01, 2021
Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia.

Michael R Verneris, Qiufei Ma, Jie Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Michael R Verneris

1 joint publications

Lida Pacaud

1 joint publications

Constantine Tam

1 joint publications

Gilles Salles